Vermont has the second lowest state fatality rate in the US (146.3 per 100K; Hawaii 112.7/100K). Mississippi (462.8/100K) and Oklahoma (458.8/100K) have the highest rates. The US average is 306.4/100K ...

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales ...

Polymerase chain reaction analysis confirmed RSV infection. The blood cell count showed normocytic anaemia (haemoglobin, 7.3 g/dL), no leucocytosis, and a normal platelet count. A comprehensive ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

The Vermont pandemic death total stands at 1,278 as of March 6, 2025, an increase of 2 from the previous week (the most ...

Phase 1 clinical trial results demonstrate BLB201's safety and ability to induce antibody and cell-mediated immune responses, positioning it as a promising candidate in the fight against RSV.

BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...

During one of the most active flu seasons in recent memory, infectious disease experts at Cancer Center say many of the ...

Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...

Researchers used cryo-EM, glycoproteomics, and modeling to generate the atomic structure of a fully glycosylated and membrane ...